Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: Preliminary report

Darrell S. Rigel, Abel M. Torres, Haines Ely

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Background: Using more than one therapeutic approach in the treatment of basal cell carcinomas (BCCs) has the potential to enhance cure rates. Materials and Methods: In this study, 57 nodular and superficial BCCs were curetted without electrodesiccation. One week later, imiquimod 5% cream therapy was initiated once daily 5 times per week for 6 weeks. At 1-year follow-up, 0 of 57 BCCs (0%) had clinical recurrences. Cosmetic results were very good to excellent. Conclusion: Combination therapy with imiquimod 5% cream followed by curettage represents an effective method for treating BCCs with a high cure rate.

Original languageEnglish
Pages (from-to)s15-s16
JournalJournal of Drugs in Dermatology
Volume7
Issue number1
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

Dive into the research topics of 'Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: Preliminary report'. Together they form a unique fingerprint.

Cite this